The Austrian Research Promotion Agency (FFG), the national funding agency for industrial research and development in Austria, has chosen our project SQUEEZE to be featured in one of their articles serie #SuccessStory, with the title: "Using biomarkers to optimize the use of rheumatism therapies". Click here to read the article (available in German). [...]
Our SQUEEZE project and coordinator Daniel Aletaha have been showcased in the Austrian magazine Trend! 👏 The article spotlights EU-funded initiatives in Austria and highlights the European Union's substantial commitment to research via the Horizon Europe program, with a special focus on successful projects like our SQUEEZE. A remarkable 600 million euros have flowed [...]
We published the 1st issue of our SQUEEZE newsletter on our Linkedin channel!! 🗞️💊 On a bi-annual basis, we will publish insights into our daily collaboration within our 13 partners Horizon Europe funded project. Here's what you'll find in this issue: Who we are. And what we do. – A quick overview of our aims [...]
SQUEEZE participation to the European Congress of Rheumatology EULAR 2023 was a success! First of all, congratulations to our SQUEEZE coordinator Daniel Aletaha for his appointment as president-elect of the EULAR - European Alliance of Associations for Rheumatology! During the congress, Daniel talked about professional and personal development in #RA, and met with our [...]
We are proud to announce that SQUEEZE will be present at the European Congress of Rheumatology 2023 in Milano! The congress is organized by the European Alliance of Associations for Rheumatology, EULAR, which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations. EULAR [...]
In January 2023 we kicked off our the Horizon Europe project SQUEEZE at the beautiful Jugendstilhörsaal of Medizinische Universität Wien. Together with 13 passionate partners from all over Europe, we started our 5 year journey towards advancing the clinical application of biomarkers to improve benefit, safety, and value of approved DMARDs for Rheumatoid Arthritis [...]
For more information about SQUEEZE Project, contact:
E-mail: contact.at.squeeze-project.eu
Funded by the European Union under grant no. 101095052, by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee grant no. 10055567 as well as the Swiss State Secretariat for Education, Research and Innovation (SERI). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or any other granting authority. Neither the European Union nor any other granting authority can be held responsible for them.
© Copyright Squeeze 2024 | All Rights Reserved | Powered by WordPress
